{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:17Z","timestamp":1772165657829,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Chlorhexidine is a widely used disinfectant in clinical settings and a broad-spectrum antimicrobial agent effective against aerobic and anaerobic bacteria. However, disinfectant resistant or non-susceptible bacteria, including antibiotic-resistant\n                      <jats:italic>Acinetobacter baumannii,<\/jats:italic>\n                      have been found. This study aimed to develop a new technique to prevent and control\n                      <jats:italic>A. baumannii<\/jats:italic>\n                      infection in the hospital setting.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Chlorhexidine combined with minocycline, doxycycline, meropenem, imipenem, levofloxacin and ciprofloxacin were tested against the 30 multidrug-resistant and extremely drug-resistant\n                      <jats:italic>A. baumannii<\/jats:italic>\n                      clinical isolates. The checkerboard test was used to calculate the fractional inhibitory concentration index according to the minimum inhibitory concentration value for chlorhexidine combined with antibiotics.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The combination of chlorhexidine with minocycline, doxycycline, meropenem, or ciprofloxacin showed synergistic responses in all clinical isolates, and more than 50% of isolates showed FICI \u22640.5. However, chlorhexidine together with imipenem or levofloxacin showed indifferent responses in 10% and 3.33% clinical isolates, respectively. In all tests, combinations of chlorhexidine with each of the above six antibiotics showed synergistic and additive effects, and inhibited the clinical isolates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      We concluded that, chlorhexidine combined with antibiotics could be used to control the risk of infection with\n                      <jats:italic>A. baumannii<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-021-05963-6","type":"journal-article","created":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T06:02:54Z","timestamp":1615960974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Combination inhibition activity of chlorhexidine and antibiotics on multidrug-resistant Acinetobacter baumannii in vitro"],"prefix":"10.1186","volume":"21","author":[{"given":"Fei","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baodong","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,17]]},"reference":[{"key":"5963_CR1","doi-asserted-by":"publisher","unstructured":"Thomas, L.et al., Development of resistance to chlorhexidine diacetate in Pseudomonas aeruginosa and the effect of a 'residual' concentration. J Hosp Infect, 2000. 46(4): p. 297\u2013303, DOI: https:\/\/doi.org\/10.1053\/jhin.2000.0851.","DOI":"10.1053\/jhin.2000.0851"},{"issue":"1","key":"5963_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1128\/CMR.12.1.147","volume":"12","author":"G McDonnell","year":"1999","unstructured":"McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999;12(1):147\u201379. https:\/\/doi.org\/10.1128\/CMR.12.1.147.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"5963_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jhin.2007.07.023","volume":"67","author":"A Borer","year":"2007","unstructured":"Borer A, Gilad J, Porat N, Megrelesvilli R, Saidel-Odes L, Peled N, Eskira S, Schlaeffer F, Almog Y. Impact of 4% chlorhexidine whole-body washing on multidrug-resistant Acinetobacter baumannii skin colonisation among patients in a medical intensive care unit. J Hosp Infect. 2007;67(2):149\u201355. https:\/\/doi.org\/10.1016\/j.jhin.2007.07.023.","journal-title":"J Hosp Infect"},{"issue":"5","key":"5963_CR4","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/j.1600-0765.2012.01470.x","volume":"47","author":"O Ozcaka","year":"2012","unstructured":"Ozcaka O, et al. Chlorhexidine decreases the risk of ventilator-associated pneumonia in intensive care unit patients: a randomized clinical trial. J Periodontal Res. 2012;47(5):584\u201392. https:\/\/doi.org\/10.1111\/j.1600-0765.2012.01470.x.","journal-title":"J Periodontal Res"},{"key":"5963_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jcrc.2015.11.011","volume":"32","author":"HY Kim","year":"2016","unstructured":"Kim HY, Lee WK, Na S, Roh YH, Shin CS, Kim J. The effects of chlorhexidine gluconate bathing on health care-associated infection in intensive care units: a meta-analysis. J Crit Care. 2016;32:126\u201337. https:\/\/doi.org\/10.1016\/j.jcrc.2015.11.011.","journal-title":"J Crit Care"},{"issue":"9","key":"5963_CR6","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1093\/jac\/dkq227","volume":"65","author":"K Kawamura-Sato","year":"2010","unstructured":"Kawamura-Sato K, Wachino JI, Kondo T, Ito H, Arakawa Y. Correlation between reduced susceptibility to disinfectants and multidrug resistance among clinical isolates of Acinetobacter species. J Antimicrob Chemother. 2010;65(9):1975\u201383. https:\/\/doi.org\/10.1093\/jac\/dkq227.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"5963_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1099\/jmm.0.000403","volume":"66","author":"WJ Liu","year":"2017","unstructured":"Liu WJ, Fu L, Huang M, Zhang JP, Wu Y, Zhou YS, Zeng J, Wang GX. Frequency of antiseptic resistance genes and reduced susceptibility to biocides in carbapenem-resistant Acinetobacter baumannii. J Med Microbiol. 2017;66(1):13\u20137. https:\/\/doi.org\/10.1099\/jmm.0.000403.","journal-title":"J Med Microbiol"},{"issue":"4","key":"5963_CR8","first-page":"E176","volume":"56","author":"F G\u00fcnther","year":"2015","unstructured":"G\u00fcnther F, Kaiser SJ, Fries T, Frank U, Mutters NT. Susceptibility of multidrug resistant clinical pathogens to a chlorhexidine formulation. J Prev Med Hyg. 2015;56(4):E176.","journal-title":"J Prev Med Hyg"},{"issue":"4","key":"5963_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2217\/fmb.11.23","volume":"6","author":"E Durante-Mangoni","year":"2011","unstructured":"Durante-Mangoni E, Zarrilli R. Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance. Future Microbiol. 2011;6(4):407\u201322. https:\/\/doi.org\/10.2217\/fmb.11.23.","journal-title":"Future Microbiol"},{"issue":"3","key":"5963_CR10","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1128\/CMR.00058-07","volume":"21","author":"AY Peleg","year":"2008","unstructured":"Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538\u201382. https:\/\/doi.org\/10.1128\/CMR.00058-07.","journal-title":"Clin Microbiol Rev"},{"key":"5963_CR11","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.3389\/fmicb.2017.01836","volume":"8","author":"F Lin","year":"2017","unstructured":"Lin F, Xu Y, Chang Y, Liu C, Jia X, Ling B. Molecular characterization of reduced susceptibility to biocides in clinical isolates of Acinetobacter baumannii. Front Microbiol. 2017;8:1836. https:\/\/doi.org\/10.3389\/fmicb.2017.01836.","journal-title":"Front Microbiol"},{"issue":"2","key":"5963_CR12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1128\/CMR.9.2.148","volume":"9","author":"E Bergogne-Berezin","year":"1996","unstructured":"Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996;9(2):148\u201365. https:\/\/doi.org\/10.1128\/CMR.9.2.148.","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"5963_CR13","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jhin.2019.08.004","volume":"103","author":"CY Fan","year":"2019","unstructured":"Fan CY, Lee WT, Hsu TC, Lee CH, Wang SP, Chen WS, Huang CH, Lee CC. Effect of chlorhexidine bathing on colonization or infection with Acinetobacter baumannii: a systematic review and meta-analysis. J Hosp Infect. 2019;103(3):284\u201392. https:\/\/doi.org\/10.1016\/j.jhin.2019.08.004.","journal-title":"J Hosp Infect"},{"issue":"5","key":"5963_CR14","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/j.1600-0765.2012.01470.x","volume":"47","author":"\u00d6 \u00d6z\u00e7aka","year":"2012","unstructured":"\u00d6z\u00e7aka \u00d6, Ba\u015fo\u011flu \u00d6K, Buduneli N, Ta\u015fbakan MS, Bacako\u011flu F, Kinane DF. Chlorhexidine decreases the risk of ventilator-associated pneumonia in intensive care unit patients: a randomized clinical trial. J Periodontal Res. 2012;47(5):584\u201392. https:\/\/doi.org\/10.1111\/j.1600-0765.2012.01470.x.","journal-title":"J Periodontal Res"},{"issue":"2","key":"5963_CR15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3343\/alm.2016.36.2.138","volume":"36","author":"H Lee","year":"2016","unstructured":"Lee H, Roh KH, Hong SG, Shin HB, Jeong SH, Song W, Uh Y, Yong D, Lee K. In vitro synergistic effects of antimicrobial combinations on extensively drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolates. Ann Lab Med. 2016;36(2):138\u201344. https:\/\/doi.org\/10.3343\/alm.2016.36.2.138.","journal-title":"Ann Lab Med"},{"issue":"2","key":"5963_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3343\/alm.2016.36.2.124","volume":"36","author":"GC Park","year":"2016","unstructured":"Park GC, Choi JA, Jang SJ, Jeong SH, Kim CM, Choi IS, Kang SH, Park G, Moon DS. In vitro interactions of antibiotic combinations of Colistin, Tigecycline, and Doripenem against extensively drug-resistant and multidrug-resistant Acinetobacter baumannii. Ann Lab Med. 2016;36(2):124\u201330. https:\/\/doi.org\/10.3343\/alm.2016.36.2.124.","journal-title":"Ann Lab Med"},{"issue":"9","key":"5963_CR17","doi-asserted-by":"publisher","first-page":"e764","DOI":"10.1016\/j.ijid.2010.02.2254","volume":"14","author":"W-H Sheng","year":"2010","unstructured":"Sheng W-H, Liao CH, Lauderdale TL, Ko WC, Chen YS, Liu JW, Lau YJ, Wang LS, Liu KS, Tsai TY, Lin SY, Hsu MS, Hsu LY, Chang SC. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii. Int J Infect Dis. 2010;14(9):e764\u20139. https:\/\/doi.org\/10.1016\/j.ijid.2010.02.2254.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"5963_CR18","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1590\/S1679-45082015RW2980","volume":"13","author":"MCN Vilela","year":"2015","unstructured":"Vilela MCN, et al. Oral care and nosocomial pneumonia: a systematic review. Einstein (Sao Paulo, Brazil). 2015;13(2):290\u20136.","journal-title":"Einstein (Sao Paulo, Brazil)"},{"key":"5963_CR19","first-page":"Cd012248","volume":"8","author":"SR Lewis","year":"2019","unstructured":"Lewis SR, et al. Chlorhexidine bathing of the critically ill for the prevention of hospital-acquired infection. Cochrane Database Syst Rev. 2019;8:Cd012248.","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"5963_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11908-016-0532-y","volume":"18","author":"S Abbas","year":"2016","unstructured":"Abbas S, Sastry S. Chlorhexidine: patient bathing and infection prevention. Curr Infect Dis Rep. 2016;18(8):25. https:\/\/doi.org\/10.1007\/s11908-016-0532-y.","journal-title":"Curr Infect Dis Rep"},{"issue":"2","key":"5963_CR21","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1128\/AAC.01959-13","volume":"58","author":"MA Jamal","year":"2014","unstructured":"Jamal MA, Rosenblatt JS, Hachem RY, Ying J, Pravinkumar E, Nates JL, Chaftari AMP, Raad II. Prevention of biofilm colonization by gram-negative bacteria on minocycline-rifampin-impregnated catheters sequentially coated with chlorhexidine. Antimicrob Agents Chemother. 2014;58(2):1179\u201382. https:\/\/doi.org\/10.1128\/AAC.01959-13.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"5963_CR22","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1128\/AAC.01318-06","volume":"51","author":"SG Sakka","year":"2007","unstructured":"Sakka SG, Glauner AK, Bulitta J\u0308B, Kinzig-Schippers M, Pfister W, Drusano GL, S\u00f6rgel F. Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial. Antimicrob Agents Chemother. 2007;51(9):3304\u201310. https:\/\/doi.org\/10.1128\/AAC.01318-06.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"5963_CR23","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1177\/0018578718779009","volume":"54","author":"S Fawaz","year":"2019","unstructured":"Fawaz S, Barton S, Whitney L, Swinden J, Nabhani-Gebara S. Stability of Meropenem after reconstitution for administration by prolonged infusion. Hosp Pharm. 2019;54(3):190\u20136. https:\/\/doi.org\/10.1177\/0018578718779009.","journal-title":"Hosp Pharm"},{"issue":"4","key":"5963_CR24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1365-2710.1994.tb00684.x","volume":"19","author":"M Mathew","year":"1994","unstructured":"Mathew M, Das Gupta V, Zerai T. Stability of ciprofloxacin in 5% dextrose and normal saline injections. J Clin Pharm Ther. 1994;19(4):261\u20132. https:\/\/doi.org\/10.1111\/j.1365-2710.1994.tb00684.x.","journal-title":"J Clin Pharm Ther"},{"issue":"19","key":"5963_CR25","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1093\/ajhp\/53.19.2309","volume":"53","author":"NA Williams","year":"1996","unstructured":"Williams NA, Bornstein M, Johnson K. Stability of levofloxacin in intravenous solutions in polyvinyl chloride bags. Am J Health Syst Pharm. 1996;53(19):2309\u201313. https:\/\/doi.org\/10.1093\/ajhp\/53.19.2309.","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"5963_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/BF02601704","volume":"1","author":"AL Barry","year":"1978","unstructured":"Barry AL, Badal RE. Stability of minocycline, doxycycline, and tetracycline stored in agar plates and microdilution trays. Curr Microbiol. 1978;1(1):33\u20136. https:\/\/doi.org\/10.1007\/BF02601704.","journal-title":"Curr Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-05963-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-021-05963-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-05963-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T06:04:34Z","timestamp":1615961074000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-05963-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,17]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5963"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-05963-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-130283\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,17]]},"assertion":[{"value":"17 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"266"}}